Sleep Disordered Breathing and Lung Transplantation

KU Leuven1 site in 1 country40 target enrollmentAugust 2010

ConditionsSleep Disordered Breathing Lung Transplantation

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Sleep Disordered Breathing
Sponsor: KU Leuven
Enrollment: 40
Locations: 1
Primary Endpoint: Prevalence of sleep disordered breathing
Last Updated: 12 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of the study is to investigate the prevalence, clinical predictors and consequences (effect on survival, chronic rejection) of sleep disordered breathing in lung transplant recipients.

Detailed Description

All patients with end-stage respiratory failure who are referred for lung transplantation and are older than 18 years old are enrolled. We collect: * Medical history * Blood pressure * Anthropometrics * Pulmonary function * Arterial blood gas * Questionnaire (QOL, ESS) * Sleep diary * Polysomnography

Registry

clinicaltrials.gov

Start Date

August 2010

End Date

September 2014

Last Updated

12 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

KU Leuven

Responsible Party

Principal Investigator

Marc Decramer

Prof. Dr.

KU Leuven

Eligibility Criteria

Inclusion Criteria

•Patients with end-stage respiratory failure who are referred for lung transplantation
•Informed consent from patient

Exclusion Criteria

•Patients who are declined for lung transplantation
•Patients \< 18 years old

Outcomes

Primary Outcomes

Prevalence of sleep disordered breathing

Time Frame: 1 year after lung transplantation

Polysomnographic evaluation

Secondary Outcomes

Pulmonary function(1 year after lung transplantation)
Investigate possible relationship between SDB and patient medical history(1 year after lung transplantation)